2nd Quarter - Report — UCB, INC. for UCB, INC. (2026)

Firm

UCB, INC.

Client

UCB, INC.

Income

—

Expenses

$710,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 5509/S. 2903 - Safe Step Act H.R. 6423/S. 864 - HELP Copays Act H.R. 1189/S. 494 - National Plan for Epilepsy Act Drug Pricing

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6423 (119th), S. 2903 (119th), S. 494 (119th), S. 864 (119th), H.R. 1189 (119th), H.R. 5509 (119th)

Trade (domestic/foreign) TRD

Tariffs

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.